Paul Wearing

The power and limits of zeroing in

A sampler of diagnostics emerging from Stanford

Doubts mount over move to end off-label drug oversight

Minds of all kinds join to hasten discoveries of new medical treatments

Musings on why evidence can persuade, but a good story compels

Why nothing really is something, and in some ways is better than anything

Serving in clinical trials offers lessons for living

The human subjects trade is booming, largely without oversight

New drug approvals ebb; doubts over testing's gold standard grow

An unusual path to motherhood brings joy to a cancer survivor